Lene Dreyer Selected Research

Infliximab (Remicade)

1/2022	Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO registries.
12/2019	Comparative Effectiveness of Certolizumab Pegol, Abatacept, and Biosimilar Infliximab in Patients With Rheumatoid Arthritis Treated in Routine Care: Observational Data From the Danish DANBIO Registry Emulating a Randomized Trial.
1/2010	Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lene Dreyer Research Topics

Disease

26	Rheumatoid Arthritis 10/2022 - 02/2009
12	Neoplasms (Cancer) 11/2021 - 12/2003
11	Psoriatic Arthritis 01/2022 - 02/2011
7	Axial Spondyloarthritis 10/2022 - 10/2015
7	Pain (Aches) 01/2022 - 12/2016
7	Fatigue 11/2021 - 11/2010
6	Necrosis 10/2022 - 02/2009
5	Infections 04/2022 - 01/2018
5	Arthritis (Polyarthritis) 01/2022 - 02/2009
4	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 02/2009
4	Rheumatic Diseases (Rheumatism) 07/2011 - 02/2009
3	Osteoarthritis 01/2022 - 01/2018
3	Ankylosing Spondylitis 01/2018 - 11/2010
2	COVID-19 04/2022 - 10/2021
2	Diabetes Mellitus 11/2021 - 05/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2021 - 04/2021
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2021 - 11/2020
2	Lymphoma (Lymphomas) 12/2017 - 01/2014
1	Osteoporotic Fractures 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 10/2021
1	Ischemic Stroke 04/2021
1	Myocardial Infarction 04/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Cutaneous Lupus Erythematosus 11/2020
1	Chronic Pain 01/2020
1	Nociceptive Pain 01/2018
1	Chronic Disease (Chronic Diseases) 01/2018
1	Melanoma (Melanoma, Malignant) 02/2017
1	Non-Radiographic Axial Spondyloarthritis 01/2017
1	Hypertension (High Blood Pressure) 05/2015
1	Multiple Sclerosis 05/2014
1	Sjogren's Syndrome (Sjogren Syndrome) 01/2014
1	Ovarian Neoplasms (Ovarian Cancer) 01/2013
1	Chronic Kidney Failure (Chronic Renal Failure) 06/2010
1	Nephritis 06/2010
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2009
1	Spondylarthropathies 02/2009
1	Ischemia 12/2003

Drug/Important Bio-Agent (IBA)

15	Biological ProductsIBA 01/2022 - 07/2015
13	Tumor Necrosis Factor InhibitorsIBA 10/2022 - 01/2013
12	Antirheumatic Agents (DMARD)IBA 04/2022 - 07/2015
9	Pharmaceutical PreparationsIBA 01/2022 - 01/2010
7	C-Reactive ProteinIBA 09/2021 - 11/2010
5	ametantrone (HAQ)IBA 10/2022 - 12/2015
5	Abatacept (Orencia)FDA Link 10/2022 - 07/2011
3	Rituximab (Mabthera)FDA Link 04/2022 - 01/2019
3	Infliximab (Remicade)FDA Link 01/2022 - 01/2010
3	GlucocorticoidsIBA 11/2021 - 01/2014
3	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 01/2014
3	tocilizumab (atlizumab)FDA Link 01/2020 - 07/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2014 - 01/2010
2	Etanercept (Enbrel)FDA Link 01/2022 - 01/2010
2	Immunologic Factors (Immunomodulators)IBA 01/2022 - 01/2014
2	amsonic acid (DAS)IBA 09/2021 - 12/2016
2	propylene diquat (PDQ(+))IBA 01/2020 - 01/2018
2	ORALIT (ORS)IBA 01/2018 - 01/2010
1	Janus Kinase InhibitorsIBA 10/2022
1	Interleukin-6 InhibitorsIBA 10/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	CannabidiolIBA 01/2022
1	CannabinoidsIBA 01/2022
1	guselkumabIBA 01/2022
1	secukinumabIBA 01/2022
1	golimumab FDA Link 01/2022
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2021
1	omega-Chloroacetophenone (Mace)IBA 04/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 04/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Certolizumab Pegol FDA Link 12/2019
1	Biosimilar PharmaceuticalsIBA 12/2019
1	Rheumatoid FactorIBA 01/2018
1	apremilastIBA 01/2018
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2017
1	ElementsIBA 08/2016
1	Prostaglandins AIBA 10/2015
1	Triglycerides (Triacylglycerol)IBA 05/2015
1	Azathioprine (Imuran)FDA LinkGeneric 01/2014
1	Antimalarials (Antimalarial Agents)IBA 01/2014
1	SteroidsIBA 01/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2014
1	CreatinineIBA 06/2010
1	Adalimumab (Humira)FDA Link 01/2010
1	Oxygen (Dioxygen)IBA 12/2003
1	Free RadicalsIBA 12/2003

Therapy/Procedure

16	Therapeutics 01/2022 - 02/2009
3	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2020 - 01/2018
2	Replacement Arthroplasty 01/2020 - 01/2019
2	Biological Therapy 01/2018 - 02/2017
1	Analgesia 01/2022
1	Pain Management 01/2022
1	Critical Care (Surgical Intensive Care) 10/2021
1	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2018
1	Duration of Therapy 11/2010